Subscribe * indicates required Email Address *First Name Last Name /* real people should not fill this in and expect good things – do not remove this or risk form bot signups */ View Past Issues BiotechReality Shots - 20/09/202620 September 2026 BiotechReality Shots- 01/09/20261 September 2026 BiotechReality Shots - 23/08/202623 August 2026 BiotechReality Shots - 10/08/202610 August 2026 BiotechReality Shots - 02/08/20262 August 2026 BiotechReality Shots - 12/07/202612 July 2026 BiotechReality Shots - 05/07/20265 July 2026
Research Healthcare & Pharmaceuticals News Novo Ozempic 2 mg MACE Analysis Shows 6% Lower Cardiovascular Risk Versus Switching to Mounjaro at EASD 2026 29 September 202629 September 2026 Clinical Trials & Data Desk
Artificial Intelligence Business Healthcare & Pharmaceuticals News AbbVie Valkai AI Partnership Deploys Purpose-Built AI Across Targeted Clinical Development Areas 29 September 202629 September 2026 BiotechReality Business Intelligence Desk
Business Healthcare & Pharmaceuticals News Novo HRS-1596 License: Novo Secures Hengrui Pharma’s Oral Once-Weekly GLP-1/GIP Agonist in Deal Worth Up to $2.6 Billion 29 September 202629 September 2026 BiotechReality Business Intelligence Desk
Business Healthcare & Pharmaceuticals News Research Merck SPR2015 KRAS G12D Inhibitor Deal Strengthens Oncology Pipeline Through $2.13 Billion Agreement 28 September 202628 September 2026 BiotechReality Business Intelligence Desk
Regulatory Approval Clinical Data Healthcare & Pharmaceuticals News AbbVie JUVMO (Tavapadon) Wins FDA Approval as First Selective D1/D5 Receptor Agonist for Parkinson’s Disease 28 September 202628 September 2026 Regulatory Intelligence Desk
Clinical Data Healthcare & Pharmaceuticals News Regulatory Merck Ifinatamab Deruxtecan BLA Withdrawn in Previously Treated ES-SCLC 27 September 202627 September 2026 Clinical Trials & Data Desk
